Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,519,446
-
Number of holders
-
354
-
Total 13F shares, excl. options
-
121,633,553
-
Shares change
-
-4,654,389
-
Total reported value, excl. options
-
$7,283,914,763
-
Value change
-
-$289,525,281
-
Put/Call ratio
-
131%
-
Number of buys
-
160
-
Number of sells
-
-180
-
Price
-
$59.91
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q3 2019
452 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q3 2019.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 354 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 121,633,553 shares
of 158,519,446 outstanding shares and own 77% of the company stock.
Largest 10 shareholders include FMR LLC (20,935,783 shares), VANGUARD GROUP INC (12,214,475 shares), Clearbridge Investments, LLC (9,290,924 shares), BAILLIE GIFFORD & CO (8,415,289 shares), BlackRock Inc. (8,350,799 shares), Bellevue Group AG (8,321,914 shares), WELLINGTON MANAGEMENT GROUP LLP (7,745,339 shares), STATE STREET CORP (3,650,783 shares), WADDELL & REED FINANCIAL INC (3,180,078 shares), and Invesco Ltd. (2,376,663 shares).
This table shows the top 354 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.